Tonix Pharmaceuticals is enrolling participants in a Phase 3 trial for fibromyalgia, the RALLY study.
For more information, please visit www.RALLYStudy.com or www.clinicaltrials.gov (NCT04508621).
- Home
- Investors
- SEC Filings
- All SEC Filings
All SEC Filings
| Date | Form | Description | Docs | XBRL | Pages |
| 02/26/14 | 4 | Rhodes John B |
|
2 | |
| 02/26/14 | 4 | Daugherty Bruce |
|
2 | |
| 02/26/14 | 4 | Lederman Seth |
|
2 | |
| 02/26/14 | 4 | Saks Samuel R |
|
2 | |
| 02/14/14 | 8-K | Current report filing |
|
28 | |
| 02/14/14 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
11 | |
| 02/13/14 | SC 13G/A | Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions |
|
7 | |
| 02/10/14 | 8-K | Current report filing |
|
30 | |
| 02/04/14 | 8-K | Current report filing |
|
4 | |
| 01/30/14 | 8-K | Current report filing |
|
3 |
